HK Stock MarketDetailed Quotes
01358 PW MEDTECH
- 1.010
- -0.030-2.88%
Market Closed Nov 15 16:08 CST
1.51BMarket Cap9.10P/E (TTM)
1.040High1.000Low4.56MVolume1.040Open1.040Pre Close4.62MTurnover0.31%Turnover Ratio8.94P/E (Static)1.50BShares1.17552wk High0.34P/B1.51BFloat Cap0.55652wk Low0.10Dividend TTM1.50BShs Float3.320Historical High0.103Dividend LFY3.85%Amplitude-0.870Historical Low1.011Avg Price1000Lot Size9.60%Div YieldTTM10.20%Div Yield LFY
PW MEDTECH Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 46.48%231.07M | ---- | -78.61%157.75M | ---- | 17.69%737.46M | ---- | 630.23%626.6M | ---- | -94.88%85.81M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -23.91%-43.83M | ---- | 38.31%-35.37M | ---- | -933.99%-57.34M | ---- | -241.02%-5.55M | ---- | -16.23%-1.63M |
| Interest expense - adjustment | ---- | -66.81%154K | ---- | -23.31%464K | ---- | -94.33%605K | ---- | -64.58%10.67M | ---- | 249.91%30.12M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.52%-113.41M | ---- | -11.97%-112.82M |
| Impairment and provisions: | ---- | -536.11%-8.68M | ---- | -95.24%1.99M | ---- | 189.76%41.83M | ---- | -6.84%14.44M | ---- | 210.07%15.5M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --40.69M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | --197K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -625.13%-8.88M | ---- | 170.08%1.69M | ---- | -124.70%-2.41M | ---- | -36.95%9.77M | ---- | 210.07%15.5M |
| -Other impairments and provisions | ---- | ---- | ---- | -91.56%300K | ---- | -23.81%3.56M | ---- | --4.67M | ---- | ---- |
| Revaluation surplus: | ---- | -75.60%61K | ---- | -97.90%250K | ---- | 578.84%11.9M | ---- | 6.24%1.75M | ---- | --1.65M |
| -Fair value of investment properties (increase) | ---- | -75.60%61K | ---- | -97.90%250K | ---- | 578.84%11.9M | ---- | 6.24%1.75M | ---- | --1.65M |
| Asset sale loss (gain): | ---- | 64,800.00%7.14M | ---- | 100.00%11K | ---- | -32.72%-731.79M | ---- | -1,575.62%-551.37M | ---- | 102.42%37.37M |
| -Loss (gain) from sale of subsidiary company | ---- | --6.1M | ---- | ---- | ---- | ---- | ---- | -2,211.26%-552.9M | ---- | 101.69%26.19M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 9,345.45%1.04M | ---- | 128.95%11K | ---- | -102.48%-38K | ---- | -86.28%1.53M | ---- | 19,170.69%11.18M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---731.75M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 25.04%98.26M | ---- | 150.15%78.59M | ---- | 10.48%31.42M | ---- | -3.29%28.44M | ---- | 38.31%29.4M |
| -Amortization of intangible assets | ---- | 37.65%30.07M | ---- | 579.38%21.84M | ---- | 0.00%3.22M | ---- | -3.28%3.22M | ---- | -25.05%3.32M |
| Unrealized exchange loss (gain) | ---- | -123.60%-12.74M | ---- | 2,431.43%54M | ---- | -128.86%-2.32M | ---- | 600.06%8.03M | ---- | -186.94%-1.61M |
| Special items | ---- | -102.84%-344K | ---- | 1,553.13%12.13M | ---- | -72.63%734K | ---- | 68.47%2.68M | ---- | -93.92%1.59M |
| Operating profit before the change of operating capital | ---- | 0.47%271.09M | ---- | 729.88%269.81M | ---- | 45.90%32.51M | ---- | -73.90%22.28M | ---- | 18.31%85.39M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 16.18%-4.57M | ---- | -193.06%-5.46M | ---- | 320.70%5.86M | ---- | -166.74%-2.66M | ---- | -20.40%3.98M |
| Accounts receivable (increase)decrease | ---- | 59.65%-11.49M | ---- | -868.23%-28.46M | ---- | -95.29%3.71M | ---- | 741.40%78.59M | ---- | -43.29%9.34M |
| Accounts payable increase (decrease) | ---- | -86.01%5.65M | ---- | 1,334.86%40.42M | ---- | 116.42%2.82M | ---- | -126.76%-17.15M | ---- | -154.66%-7.56M |
| Special items for working capital changes | ---- | -170.15%-5.09M | ---- | 1,230.22%7.26M | ---- | 0.00%-642K | ---- | -103.87%-642K | ---- | 8,403.00%16.61M |
| Cash from business operations | 53.72%155.62M | -9.87%255.59M | -31.66%101.24M | 540.74%283.57M | 177.39%148.15M | -44.97%44.26M | 25.21%53.41M | -25.37%80.42M | 66.22%42.65M | 0.43%107.75M |
| Other taxs | 21.10%-17.02M | -210.88%-44.56M | -510.84%-21.58M | -104.39%-14.33M | 41.61%-3.53M | -216.61%-7.01M | -131.14%-6.05M | 71.45%-2.22M | 35.03%-2.62M | 19.03%-7.76M |
| Net cash from operations | 73.98%138.6M | -21.62%211.03M | -44.91%79.66M | 622.91%269.23M | 205.36%144.62M | -52.38%37.24M | 18.29%47.36M | -21.79%78.2M | 85.07%40.04M | 2.34%99.99M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 65.49%27.91M | 23.91%43.83M | 27.91%16.86M | -38.31%35.37M | -58.06%13.18M | 933.99%57.34M | 1,875.61%31.43M | 241.02%5.55M | 189.27%1.59M | 16.23%1.63M |
| Loan receivable (increase) decrease | ---- | 68.13%-29M | ---24.5M | 49.44%-91M | ---- | ---180M | ---180M | ---- | ---- | ---- |
| Sale of fixed assets | --111K | 3,236.04%3.7M | ---- | -18.38%111K | ---- | -96.99%136K | ---- | --4.52M | 3,537.10%4.51M | ---- |
| Purchase of fixed assets | -46.52%-7.53M | 36.90%-7.76M | 81.18%-5.14M | -67.49%-12.29M | -182.00%-27.32M | -144.42%-7.34M | -529.03%-9.69M | 86.46%-3M | -13.82%-1.54M | -421.86%-22.17M |
| Purchase of intangible assets | 77.56%-4M | -268.26%-34.61M | -723.64%-17.84M | ---9.4M | ---2.17M | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | --35.99M | ---- | ---- | ---- | 40.59%2.91B | 307.04%2.91B | --2.07B | --714.23M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---1.01B | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | -88.01%1.37M | 354.30%663.73M | -92.46%11.39M | -44.87%146.1M | --151.05M | --265M | ---- | ---- | ---- | ---- |
| Cash on investment | 49.11%-11.93M | -411.17%-702.55M | 75.59%-23.44M | 66.15%-137.44M | -683.40%-96.01M | -8,229.54%-405.98M | -151.46%-12.26M | 80.67%-4.87M | 81.44%-4.87M | 96.28%-25.21M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---1.01B | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 113.88%5.92M | 97.54%-26.67M | 95.62%-42.66M | -141.05%-1.08B | -135.63%-975.04M | 27.36%2.64B | 283.33%2.74B | 4,623.63%2.07B | 2,749.84%713.92M | 95.01%-45.76M |
| Net cash before financing | 290.57%144.52M | 122.67%184.37M | 104.46%37M | -130.41%-813.1M | -129.83%-830.43M | 24.46%2.67B | 269.26%2.78B | 3,861.09%2.15B | 14,301.47%753.96M | 106.61%54.23M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --2.8M | ---- | ---- | ---- | ---- | ---- | ---- | 80.00%18M | ---- | -98.24%10M |
| Refund | ---- | ---- | ---- | -196.50%-83.02M | ---- | 95.22%-28M | 98.01%-11.64M | ---585.4M | ---585.4M | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.86%62K |
| Interest paid - financing | ---118K | 66.81%-154K | ---- | 23.18%-464K | 61.37%-209K | 94.34%-604K | 94.82%-541K | 64.59%-10.66M | 31.39%-10.44M | -249.80%-30.11M |
| Dividends paid - financing | ---- | ---121.6M | ---- | ---- | ---- | ---2.06B | ---2.06B | ---- | ---- | ---- |
| Absorb investment income | ---- | 6,900.00%140M | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---4.3M | ---- | ---- | ---3.06M | ---3.04M | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -64.36%-332K | ---- | ---202K |
| Adjustment item of financing business | ---- | ---40K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -165.62%-2.19M | 120.59%17.53M | 74.68%-826K | 95.93%-85.16M | 99.84%-3.26M | -261.55%-2.09B | -248.04%-2.07B | -2,755.71%-578.4M | -9,330.76%-596.02M | -103.62%-20.25M |
| Effect of rate | -43.40%1.07M | 227.05%5.84M | 140.67%1.89M | -831.85%-4.6M | -629.92%-4.64M | 198.90%628K | -821.59%-635K | -84.06%-635K | -88.83%88K | 92.71%-345K |
| Net Cash | 293.42%142.32M | 122.48%201.9M | 104.34%36.18M | -254.24%-898.26M | -217.48%-833.69M | -62.90%582.36M | 349.33%709.64M | 4,519.97%1.57B | 1,458.09%157.93M | 113.04%33.98M |
| Begining period cash | 15.03%1.59B | -39.52%1.38B | -39.52%1.38B | 34.26%2.28B | 34.26%2.28B | 1,183.42%1.7B | 1,183.42%1.7B | 33.99%132.6M | 33.99%132.6M | -72.83%98.96M |
| Cash at the end | 22.05%1.73B | 15.03%1.59B | -1.83%1.42B | -39.52%1.38B | -40.00%1.45B | 34.26%2.28B | 729.54%2.41B | 1,183.42%1.7B | 229.79%290.62M | 33.99%132.6M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.7B | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.7B | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data